Annapolis Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.37K Buy
123
+17
+16% +$797 ﹤0.01% 309
2024
Q2
$4.4K Hold
106
﹤0.01% 315
2024
Q1
$5.75K Sell
106
-80
-43% -$4.08K ﹤0.01% 304
2023
Q4
$9.54K Sell
186
-2,900
-94% -$152K ﹤0.01% 355
2023
Q3
$179K Hold
3,086
0.05% 113
2023
Q2
$197K Hold
3,086
0.06% 111
2023
Q1
$214K Hold
3,086
0.06% 106
2022
Q4
$222K Sell
3,086
-110
-3% -$8.29K 0.07% 107
2022
Q3
$227K Buy
3,196
+106
+3% +$7.69K 0.08% 102
2022
Q2
$238K Sell
3,090
-132
-4% -$10.1K 0.09% 97
2022
Q1
$235K Hold
3,222
0.08% 98
2021
Q4
$201K Buy
3,222
+56
+2% +$3.29K 0.06% 108
2021
Q3
$187K Hold
3,166
0.06% 106
2021
Q2
$212K Sell
3,166
-326
-9% -$21.3K 0.07% 100
2021
Q1
$220K Buy
3,492
+1,600
+85% +$99.5K 0.08% 89
2020
Q4
$117K Buy
+1,892
New +$116K 0.05% 107

Other funds holding BMY

Annapolis Financial Services's BMY Position: Q3 2024 in Review

Annapolis Financial Services increased its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2024, buying an estimated $797 and bringing the position to 123 shares worth $6.37K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

Annapolis Financial Services first reported a position in BMY in Q4 2020 and has held it in 16 quarters since. The position peaked at $238K in Q2 2022. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Annapolis Financial Services held 123 shares of Bristol-Myers Squibb worth $6.37K as of Q3 2024.
  • Annapolis Financial Services bought 17 Bristol-Myers Squibb shares in Q3 2024, an estimated $797.
  • Bristol-Myers Squibb made up ﹤0.01% of Annapolis Financial Services's portfolio in Q3 2024, its #309 holding.
  • Annapolis Financial Services first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 16 quarters since.
  • Annapolis Financial Services's Bristol-Myers Squibb position peaked at $238K in Q2 2022.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.